S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
LON:CSRT

Consort Medical plc (CSRT.L) - CSRT Share Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
1,010
▼
1,010
52-Week Range
N/A
Volume
768 shs
Average Volume
520,697 shs
Market Capitalization
£504.60 million
P/E Ratio
127.85
Dividend Yield
2.75%
Price Target
N/A

CSRT stock logo

About Consort Medical plc (CSRT.L) (LON:CSRT) Stock

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is headquartered in Hemel Hempstead, the United Kingdom.

Receive CSRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Consort Medical plc (CSRT.L) and its competitors with MarketBeat's FREE daily newsletter.

CSRT Stock News Headlines

February 23, 2023 | msn.com
Queen Consort Camilla is backing new awards to honour “unsung heroes” who volunteer in their communities
September 29, 2022 | investing.com
United Medical Group Cy Plc DRC (GEMCDR)
March 24, 2023 | Investor Place Media (Ad)
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
July 23, 2022 | seekingalpha.com
Intuitive Surgical, Inc.'s (ISRG) CEO Gary Guthart on Q2 2022 Results - Earnings Call Transcript
July 16, 2021 | marketwatch.com
Global Surgical Needle Market Size, Share Revenue to Grow At 4.1% CAGR Through 2024
July 14, 2021 | uk.finance.yahoo.com
Medical Device Contract Manufacturing Market Worth US$ 228.78 Billion by 2031: Visiongain Research Inc.
July 13, 2021 | marketwatch.com
Global Electroencephalography (EEG) Systems/Devices Market Size, Share to Bolster At 7.6% CAGR Through 2025
July 13, 2021 | marketwatch.com
Medical Device Outsourced Manufacturing Market Latest Research On Industry Growth, Trends, Top Players, & Key Regions By 2027
March 24, 2023 | Investor Place Media (Ad)
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
July 8, 2021 | marketwatch.com
Medical Device Outsourced Manufacturing Market Size, Share, Value, And Competitive Landscape 2021-2027
July 3, 2021 | marketwatch.com
Global Life Sciences Analytics Market Analysis, Size, Share, Drivers, Restraints, Opportunities and Threats by 2025
July 1, 2021 | au.finance.yahoo.com
How much texting is too much texting in a relationship?
June 28, 2021 | marketwatch.com
Extra Corporeal Membrane Oxygenation (ECMO) System Market Trends- Industry Analysis, Share, Growth, Product, Top Key Players and Forecast 2028
June 22, 2021 | marketwatch.com
Global Cardiac Surgical Devices Market Size, Share to Expand At 3.4% CAGR Through 2025
June 20, 2021 | benzinga.com
Global Medical Device Contract Manufacturing Market Report 2021-2027: Class I Segment is Projected to Reach $36.5 Billion
June 19, 2021 | ca.finance.yahoo.com
Global green hydrogen market size to showcase lucrative growth trends over 2021-2026
June 18, 2021 | marketwatch.com
Medical Device Contract Manufacturing Market Size Worth $ 97.52 Bn by 2027: Precedence Research
June 11, 2021 | ca.finance.yahoo.com
Royal family remembers ‘grandpa’ Philip on his 100th birthday
June 8, 2021 | marketwatch.com
Vascular Closure Device Market Analysis with Key Players, Applications, Trends and Forecasts to 2027
June 2, 2021 | nytimes.com
Covid Live Updates: AstraZeneca In Talks to Switch Factories for Vaccine Production for U.S. Government
May 26, 2021 | marketwatch.com
Chronic Hemodialysis Catheter Market Share to Record 3.7% CAGR Through 2027
May 26, 2021 | ca.finance.yahoo.com
Who is Sasha Johnson, the Black Lives Matter activist shot in London?
May 19, 2021 | nz.finance.yahoo.com
Outlook on the Pharmaceuticals Contract Development & Manufacturing Global Market to 2026 - Impact of COVID-19 with Ansoff Analysis
May 4, 2021 | marketwatch.com
Medical Device Contract Manufacturing Market to be US$ 97.52 Billion Opportunity by 2027
May 1, 2021 | ca.finance.yahoo.com
Ayurcann Enters Into Supply Agreements With Cannmart and Patient Choice
April 29, 2021 | seekingalpha.com
Medical Device Contract Manufacturing Market Development And Future Trends
April 23, 2021 | in.finance.yahoo.com
The Queen shares a moving birthday message following Prince Philip's death
See More Headlines
Receive CSRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Consort Medical plc (CSRT.L) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:CSRT
CUSIP
N/A
CIK
N/A
Web
www.consortmedical.com
Phone
+44-1442-867920
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
127.85
Forward P/E Ratio
0.16
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
55.58
Current Ratio
1.83
Quick Ratio
1.16

Sales & Book Value

Annual Sales
£298.60 million
Price / Sales
1.69
Cash Flow
GBX 30.20 per share
Price / Cash Flow
33.44
Book Value
GBX 465.50 per share
Price / Book
2.17

Miscellaneous

Outstanding Shares
49,960,600
Free Float
N/A
Market Cap
£504.60 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Jonathan M. Glenn (Age 50)
    CEO & Director
  • Mr. Paul Hayes (Age 52)
    CFO & Exec. Director
  • Mr. Andrew Jackson
    Group Gen. Counsel & Company Sec.
  • Ms. Lisa King
    Director of HR
  • Colin Leeder
    Group Financial Controller

Key Competitors

View All Competitors













CSRT Stock - Frequently Asked Questions

How have CSRT shares performed in 2023?

Consort Medical plc (CSRT.L)'s stock was trading at GBX 1,010 at the start of the year. Since then, CSRT stock has increased by 0.0% and is now trading at GBX 1,010.
View the best growth stocks for 2023 here.

Is Consort Medical plc (CSRT.L) a good dividend stock?

Consort Medical plc (CSRT.L) (LON:CSRT) pays an annual dividend of GBX 0.28 per share and currently has a dividend yield of 2.75%. The dividend payout ratio is 3.54%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CSRT.

What other stocks do shareholders of Consort Medical plc (CSRT.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Consort Medical plc (CSRT.L) investors own include Chubb (CB), Newcrest Mining (NCM), Petrel Resources (PET), Barrick Gold (ABX), Ascot Mining Plc Lon (ATMGF), Bank of Ireland Group (BKRIY), Caleres (CAL), Choice Hotels International (CHH), Colony Capital (CLNY) and JD Sports Fashion (JD).

What is Consort Medical plc (CSRT.L)'s stock symbol?

Consort Medical plc (CSRT.L) trades on the London Stock Exchange (LON) under the ticker symbol "CSRT."

How do I buy shares of Consort Medical plc (CSRT.L)?

Shares of CSRT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Consort Medical plc (CSRT.L)'s stock price today?

One share of CSRT stock can currently be purchased for approximately GBX 1,010.

How much money does Consort Medical plc (CSRT.L) make?

Consort Medical plc (CSRT.L) (LON:CSRT) has a market capitalization of £504.60 million and generates £298.60 million in revenue each year.

How can I contact Consort Medical plc (CSRT.L)?

Consort Medical plc (CSRT.L)'s mailing address is Ste D, Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ, United Kingdom. The official website for the company is www.consortmedical.com. The company can be reached via phone at +44-1442-867920.

This page (LON:CSRT) was last updated on 3/24/2023 by MarketBeat.com Staff